BioMed Research International / 2020 / Article / Tab 2 / Research Article
Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults Table 2 Participants meeting SPRINT eligibility criterion by hypertension status.
Hypertension No hypertension Treated1 Untreated Sample, N 1,225 2,269 542 Socioeconomic background Age (years) Gender (male, %) 380 (31.0%) 775 (34.2%) 126 (23.3%) Educational level None 132 (10.8%) 298 (13.2%) 60 (11.1%) Primary 405 (33.1%) 842 (37.3%) 187 (34.8%) Secondary/high school/higher secondary 491 (40.2%) 861 (38.1%) 207 (38.5%) Trade school/college/university 194 (15.9%) 258 (11.4%) 84 (15.6%) Risk factors of hypertension Heart rate, beats/min Total cholesterol, mg/dl High-density lipoprotein, mg/dl Estimated glomerular filtration rate, ml/min/1.73 m2 Current smoking 214 (17.6%) 591 (26.6%) 95 (18.3%) 724 (59.1%) 1,127 (49.7%) 215 (39.7%) Framingham risk score <10% 31 (2.6%) 125 (5.7%) 107 (20.9%) 10%-20% 465 (38.3%) 1,176 (53.4%) 319 (62.2%) >20% 717 (59.1%) 900 (40.9%) 87 (16.9%) Physical activity Low 125 (10.4%) 309 (14.1%) 61 (12.0%) Moderate 571 (47.6%) 1,008 (46.0%) 225 (44.1%) High 503 (42.0%) 873 (39.9%) 224 (43.9%) Blood pressure measurement SBP(mmHg) 130-139 mmHg 203 (16.6%) 165 (7.3%) 542 (100%) ≥140 mmHg 1,022 (83.4%) 2,104 (92.7%) 0 DBP(mmHg) 80-89 mmHg 426 (34.8%) 703 (31.0%) 326 (60.2%) ≥90 mmHg 640 (52.2%) 1,275 (56.2%) 0
Reported as
or number (%). Abbreviations: DBP: diastolic blood pressure. SBP: systolic blood pressure. SPRINT: Systolic Blood Pressure Intervention Trial.
1 Treated hypertension was defined by self-reported use of antihypertensive dedication with 1 or more classes.